Literature DB >> 20859667

Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.

Attila Kumánovics1, Sherrie L Perkins, Heather Gilbert, Melissa H Cessna, Nancy H Augustine, Harry R Hill.   

Abstract

The Job or hyper-immunoglobulinemia E syndrome is a primary immunodeficiency that is usually inherited in an autosomal dominant fashion. With the discovery of mutations in the STAT3 gene in the majority of autosomal dominant cases, it is now possible to make a molecular diagnosis of hyper-IgE syndrome. Both primary and secondary immunodeficiencies, including hyper-IgE syndrome, may predispose for malignancies, especially lymphomas, mainly mature B cell lymphomas, and classical Hodgkin lymphoma. Here, we report of a 48-year-old male with hyper-IgE syndrome who developed a primary parotid gland diffuse large B cell lymphoma. Analysis for STAT3 mutations demonstrated that the causal mutation of hyper-IgE syndrome, R382Q, arose de novo in the patient and it was transmitted to three of his five children, all three of whom are clinically affected. We review the literature regarding lymphoma in hyper-IgE syndrome and the possible etiologic relationship with STAT3 mutations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859667     DOI: 10.1007/s10875-010-9452-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  57 in total

1.  Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.

Authors:  Qian Zhang; Puthryaveett N Raghunath; Liquan Xue; Miroslaw Majewski; David F Carpentieri; Niels Odum; Stephan Morris; Tomasz Skorski; Mariusz A Wasik
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

2.  Hodgkin's disease in a child with hyperimmunoglobulin E syndrome.

Authors:  S J Lin; J L Huang; K H Hsieh
Journal:  Pediatr Hematol Oncol       Date:  1998 Sep-Oct       Impact factor: 1.969

3.  The development of invasive vulvar cancer in a patient with Job's syndrome, a rare immunodeficient condition.

Authors:  T J Clark; J J Herod; S Kehoe; D M Luesley
Journal:  Br J Obstet Gynaecol       Date:  1998-04

4.  Burkitt's lymphoma developing in a 7-year-old boy with hyper-IgE syndrome.

Authors:  L J Gorin; S C Jeha; M P Sullivan; H M Rosenblatt; W T Shearer
Journal:  J Allergy Clin Immunol       Date:  1989-01       Impact factor: 10.793

5.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses.

Authors:  S D Davis; J Schaller; R J Wedgwood
Journal:  Lancet       Date:  1966-05-07       Impact factor: 79.321

6.  STAT3 is constitutively activated in Hodgkin cell lines.

Authors:  D Kube; U Holtick; M Vockerodt; T Ahmadi; B Haier; I Behrmann; P C Heinrich; V Diehl; H Tesch
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

7.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Authors:  Guilian Niu; Kenneth L Wright; Mei Huang; Lanxi Song; Eric Haura; James Turkson; Shumin Zhang; Tianhong Wang; Dominic Sinibaldi; Domenico Coppola; Richard Heller; Lee M Ellis; James Karras; Jacqueline Bromberg; Drew Pardoll; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

8.  Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.

Authors:  Hong Jiao; Beáta Tóth; Melinda Erdos; Ingegerd Fransson; Eva Rákóczi; István Balogh; Zoltán Magyarics; Beáta Dérfalvi; Gabriella Csorba; Anna Szaflarska; Andre Megarbane; Carlo Akatcherian; Ghassan Dbaibo; Eva Rajnavölgyi; Lennart Hammarström; Juha Kere; Gérard Lefranc; László Maródi
Journal:  Mol Immunol       Date:  2008-08-15       Impact factor: 4.407

9.  Genomic changes in progression of low-grade gliomas.

Authors:  Ahmed Idbaih; Rosana Carvalho Silva; Emmanuelle Crinière; Yannick Marie; Catherine Carpentier; Blandine Boisselier; Sophie Taillibert; Audrey Rousseau; Karima Mokhtari; François Ducray; Joelle Thillet; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2008-07-11       Impact factor: 4.130

10.  Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Authors:  Cristina Woellner; E Michael Gertz; Alejandro A Schäffer; Macarena Lagos; Mario Perro; Erik-Oliver Glocker; Maria C Pietrogrande; Fausto Cossu; José L Franco; Nuria Matamoros; Barbara Pietrucha; Edyta Heropolitańska-Pliszka; Mehdi Yeganeh; Mostafa Moin; Teresa Español; Stephan Ehl; Andrew R Gennery; Mario Abinun; Anna Breborowicz; Tim Niehues; Sara Sebnem Kilic; Anne Junker; Stuart E Turvey; Alessandro Plebani; Berta Sánchez; Ben-Zion Garty; Claudio Pignata; Caterina Cancrini; Jiri Litzman; Ozden Sanal; Ulrich Baumann; Rosa Bacchetta; Amy P Hsu; Joie N Davis; Lennart Hammarström; E Graham Davies; Efrem Eren; Peter D Arkwright; Jukka S Moilanen; Dorothee Viemann; Sujoy Khan; László Maródi; Andrew J Cant; Alexandra F Freeman; Jennifer M Puck; Steven M Holland; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

View more
  21 in total

1.  A rare primary immunodeficiency.

Authors:  Poornima Nagaraj; Shobhana Sivathanu; Sowmya Sampath; Nithiyanantham Ramakrishnan
Journal:  BMJ Case Rep       Date:  2014-09-24

2.  A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.

Authors:  Andrea M Siegel; Jennifer Heimall; Alexandra F Freeman; Amy P Hsu; Erica Brittain; Jason M Brenchley; Daniel C Douek; Gary H Fahle; Jeffrey I Cohen; Steven M Holland; Joshua D Milner
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

Review 3.  Hyperimmunoglobulin E syndromes in pediatrics.

Authors:  Qian Zhang; Helen C Su
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

Review 4.  Targeting the interleukin-6/Jak/stat pathway in human malignancies.

Authors:  Pasquale Sansone; Jacqueline Bromberg
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

5.  Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Daniel J Lindner; Robert R Lorenz; Eric Lamarre; Xiao Weihua; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

6.  Diffuse Large B-Cell Lymphoma and Job's Syndrome: A Case Report.

Authors:  Rahmat Cahyanur; Sari Rahmawati
Journal:  Maedica (Bucur)       Date:  2020-06

7.  Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease.

Authors:  Dror S Shouval; Christen L Ebens; Ryan Murchie; Katelyn McCann; Raja Rabah; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-07       Impact factor: 2.839

8.  Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.

Authors:  Shiguo Zhu; Prasad V Phatarpekar; Cecele J Denman; Vladimir V Senyukov; Srinivas S Somanchi; Hoainam T Nguyen-Jackson; Emily M Mace; Alexandra F Freeman; Stephanie S Watowich; Jordan S Orange; Steven M Holland; Dean A Lee
Journal:  Blood       Date:  2014-06-02       Impact factor: 22.113

9.  STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.

Authors:  Andres Jerez; Michael J Clemente; Hideki Makishima; Hanna Koskela; Francis Leblanc; Kwok Peng Ng; Thomas Olson; Bartlomiej Przychodzen; Manuel Afable; Ines Gomez-Segui; Kathryn Guinta; Lisa Durkin; Eric D Hsi; Kathy McGraw; Dan Zhang; Marcin W Wlodarski; Kimmo Porkka; Mikkael A Sekeres; Alan List; Satu Mustjoki; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

10.  Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.

Authors:  Megan L Ives; Cindy S Ma; Umaimainthan Palendira; Anna Chan; Jacinta Bustamante; Stephanie Boisson-Dupuis; Peter D Arkwright; Dan Engelhard; Diana Averbuch; Klaus Magdorf; Joachim Roesler; Jane Peake; Melanie Wong; Stephen Adelstein; Sharon Choo; Joanne M Smart; Martyn A French; David A Fulcher; Matthew C Cook; Capucine Picard; Anne Durandy; Miyuki Tsumura; Masao Kobayashi; Gulbu Uzel; Jean-Laurent Casanova; Stuart G Tangye; Elissa K Deenick
Journal:  J Allergy Clin Immunol       Date:  2013-07-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.